atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Focusing where the most people have the fewest options
We focus on mental health disorders where patients have limited or no effective treatment options.


Programs
Developing patient-first, evidence-based therapies
We aim to develop rapid-acting, effective and durable mental health treatments for large-scale patient impact.
Team
Leading with empathy, backed by deep expertise
Our diverse and dedicated team of leading experts and scientists is united by a common goal: to transform mental health care for patients.